Lv4
758 积分 2022-08-30 加入
IcoSema: unveiling the future of diabetes management from a clinical pharmacology perspective
1个月前
已完结
IcoSema and the evolution of fixed-ratio insulin–GLP-1 receptor agonist therapies
1个月前
已完结
Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis
2个月前
已完结
Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
2个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
3个月前
已完结
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
3个月前
已完结
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease
3个月前
已完结
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
3个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
3个月前
已完结
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study
4个月前
已完结
皖公网安备34019202002308
